PKM and non-small cell lung carcinoma: In vitro experiments confirmed that, upon treatment with PKM2‐overexpressing NSCLC cell lysates, GP@Gel Nap‐T underwent a gel‐to‐solution transition with the release of PTX and GDC0919.